Press Release: Adtalem Global Education Announces Second Quarter Fiscal Year 2026 Conference Call

Dow Jones
01/05
CHICAGO--(BUSINESS WIRE)--January 05, 2026-- 

Adtalem Global Education Inc. $(ATGE)$, the largest healthcare educator in the United States, announced today it will release its second quarter fiscal year 2026 results on Wednesday, Jan. 28, 2026, after market close, followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) the same day to discuss the results.

This call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating "Adtalem earnings call" or by using conference ID: 13757746. The call will be simulcast through the Adtalem investor relations website at: https://investors.adtalem.com. Adtalem will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13757746, or visit the Adtalem investor relations website.

About Adtalem Global Education

Adtalem Global Education is the largest provider of healthcare education in the U.S., shaping the future of healthcare by preparing a dynamic workforce with high-quality academic programs. We innovate education pathways, align with industry needs and empower individuals to reach their full potential. Our commitment to excellence and access is reflected in our expansive network of institutions, serving over 97,000 students and supported by a strong community of approximately 365,000 alumni and over 10,000 dedicated employees. Visit Adtalem.com for more information and follow us on LinkedIn and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260105123655/en/

 
    CONTACT:    Investor Contact: Jay Spitzer 

Investor.Relations@Adtalem.com

+1 312-906-6600

Media Contact: Maureen Bender

AdtalemMedia@Adtalem.com

+1 313-319-4732

 
 

(END) Dow Jones Newswires

January 05, 2026 08:03 ET (13:03 GMT)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10